Clinical Trials Browser

Lymphoma, Large B-Cell, Diffuse × efineptakin alfa × 1 year × Clear all

NCT05075603 2025-10-23

Relapsed/Refractory Large B-cell Lymphoma With NT-I7 Post-CD19 CAR T-cell Therapy

Phase 1 Completed

Lymphoma, Large B-Cell, Diffuse